| pubmed-article:10024559 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C0036330 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C1423842 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C0439667 | lld:lifeskim |
| pubmed-article:10024559 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:10024559 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10024559 | pubmed:dateCreated | 1999-3-12 | lld:pubmed |
| pubmed-article:10024559 | pubmed:abstractText | In murine schistosomiasis mansoni, CD4(+) Th1 and Th2 cells participate in the ovum-induced granulomatous inflammation. Previous studies showed that the interleukin-12 (IL-12)-induced Th1 response strongly suppressed the Th2-cell-mediated pulmonary granuloma development in naive or primed mice. However, liver granulomas were only moderately suppressed in egg-vaccinated, recombinant IL-12 (rIL-12)-treated infected mice. The present study shows that repeated rIL-12 injections given during early granuloma development at 5 to 7 weeks after infection prolonged the Th1 phase and resulted in gamma interferon-mediated suppression of liver granulomas. The timing is crucial: if given at 6 to 8 weeks, during the Th2-dominated phase of florid granuloma growth, the treatment is ineffective. Daily injections of rIL-12 given between 5 and 7.5 weeks during the period of granuloma growth achieved a somewhat-stronger diminution in granuloma growth with less deposition of collagen but caused 60% mortality and liver pathology. In contrast, combined treatment with rIL-12 and anti-IL-4-anti-IL-10 monoclonal antibody (MAb) injections given during the Th2 phase strongly inhibited liver granuloma growth without mortality. The diminished inflammatory response was accompanied by less deposition of collagen in the liver. Moreover, neutralization of endogenous IL-12 by anti-IL-12 MAbs effectively decreased the early Th1 phase (between 5 and 6 weeks after infection) but not the developing Th2 phase (5 to 7 weeks) of granuloma development. These studies indicate that the granulomatous response in infected mice can be manipulated by utilizing the Th1-Th2-subset antagonism with potential salutary results in the amelioration of fibrous pathology. | lld:pubmed |
| pubmed-article:10024559 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10024559 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10024559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024559 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10024559 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:10024559 | pubmed:issn | 0019-9567 | lld:pubmed |
| pubmed-article:10024559 | pubmed:author | pubmed-author:BoothG HGH | lld:pubmed |
| pubmed-article:10024559 | pubmed:author | pubmed-author:WhitfieldJ... | lld:pubmed |
| pubmed-article:10024559 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10024559 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:10024559 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10024559 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10024559 | pubmed:pagination | 1187-93 | lld:pubmed |
| pubmed-article:10024559 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:meshHeading | pubmed-meshheading:10024559... | lld:pubmed |
| pubmed-article:10024559 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10024559 | pubmed:articleTitle | Enhanced Th1 and dampened Th2 responses synergize to inhibit acute granulomatous and fibrotic responses in murine schistosomiasis mansoni. | lld:pubmed |
| pubmed-article:10024559 | pubmed:affiliation | Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. dboros@med.wayne.edu | lld:pubmed |
| pubmed-article:10024559 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10024559 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024559 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024559 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024559 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024559 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024559 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024559 | lld:pubmed |
